Discontinued — last reported Q3 '22
Elevance Health Commercial & Specialty Business Segment — Reportable segments operating revenues decreased by 0.6% to $10.49B in Q3 2022 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growth in membership or premium pricing power, while a decrease may signal market share loss or competitive pricing pressure.
This metric represents the total revenue generated by the commercial and specialty business segment, encompassing premiu...
Comparable to commercial segment revenues reported by other large diversified health insurers like UnitedHealth Group or Cigna.
elv_segment_commercial_and_specialty_business_reportable_segments_operating_revenues| Q2 '21 | Q3 '21 | Q2 '22 | Q3 '22 | |
|---|---|---|---|---|
| Value | $9.55B | $9.86B | $10.56B | $10.49B |
| QoQ Change | — | +3.3% | +7.1% | -0.6% |
| YoY Change | — | — | +10.6% | +6.4% |